European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.
Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.
Two key positions have been created at Almac Group, the pharmaceutical
contract development and manufacturing organisation, expanding their
global marketing team. Matt Cocking joins as Market Development Director
for their Clinical Technologies business unit and will be responsible
for developing the marketing plan in line with business strategy. Matt
has over 10 years’ experience as a senior marketing leader and formally
held the position of Director of Marketing at Philadelphia based
clinical trial software solutions company, Y Prime. More info >>
High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts
As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles. More info >>